Deoxypyridinoline: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
== Deoxypyridinoline == | |||
[[File:Deoxypyridinoline.svg|thumb|right|Chemical structure of deoxypyridinoline]] | |||
Deoxypyridinoline is a [[ | '''Deoxypyridinoline''' (DPD) is a [[biochemical marker]] of [[bone resorption]]. It is a crosslinking compound found in [[collagen]] of [[bone]] and [[dentin]]. DPD is released into the [[bloodstream]] during the process of bone degradation and is subsequently excreted in the [[urine]]. | ||
== Structure and Function == | |||
Deoxypyridinoline is a [[pyridinium]] crosslink that stabilizes the [[collagen]] matrix in bone. It is formed by the enzymatic action of [[lysyl oxidase]] on [[lysine]] residues in collagen. The presence of DPD in bone provides structural integrity and resistance to tensile forces. | |||
== Clinical Significance == | == Clinical Significance == | ||
The measurement of | The measurement of deoxypyridinoline levels in urine is used as a marker for bone resorption. Elevated levels of DPD are indicative of increased bone turnover, which can occur in conditions such as [[osteoporosis]], [[Paget's disease of bone]], and [[hyperparathyroidism]]. | ||
=== Osteoporosis === | |||
In [[osteoporosis]], the balance between bone resorption and bone formation is disrupted, leading to a net loss of bone mass. Monitoring DPD levels can help assess the effectiveness of [[osteoporosis treatment]]s. | |||
=== Paget's Disease === | |||
[[Paget's disease of bone]] is characterized by excessive and disorganized bone remodeling. DPD levels can be significantly elevated in this condition, reflecting increased bone resorption. | |||
=== Hyperparathyroidism === | |||
In [[hyperparathyroidism]], increased secretion of [[parathyroid hormone]] leads to increased bone resorption. DPD levels can be used to monitor the severity of bone turnover in affected individuals. | |||
== Measurement == | |||
Deoxypyridinoline can be measured using [[immunoassay]] techniques. Urinary DPD levels are often expressed relative to [[creatinine]] to account for variations in urine concentration. This measurement is non-invasive and provides valuable information about bone metabolism. | |||
== Related Pages == | |||
* [[Bone resorption]] | |||
* [[Collagen]] | |||
* [[Osteoporosis]] | |||
* [[Paget's disease of bone]] | |||
* [[Hyperparathyroidism]] | |||
[[Category: | [[Category:Biomarkers]] | ||
[[Category:Bone | [[Category:Bone physiology]] | ||
Latest revision as of 11:35, 15 February 2025
Deoxypyridinoline[edit]

Deoxypyridinoline (DPD) is a biochemical marker of bone resorption. It is a crosslinking compound found in collagen of bone and dentin. DPD is released into the bloodstream during the process of bone degradation and is subsequently excreted in the urine.
Structure and Function[edit]
Deoxypyridinoline is a pyridinium crosslink that stabilizes the collagen matrix in bone. It is formed by the enzymatic action of lysyl oxidase on lysine residues in collagen. The presence of DPD in bone provides structural integrity and resistance to tensile forces.
Clinical Significance[edit]
The measurement of deoxypyridinoline levels in urine is used as a marker for bone resorption. Elevated levels of DPD are indicative of increased bone turnover, which can occur in conditions such as osteoporosis, Paget's disease of bone, and hyperparathyroidism.
Osteoporosis[edit]
In osteoporosis, the balance between bone resorption and bone formation is disrupted, leading to a net loss of bone mass. Monitoring DPD levels can help assess the effectiveness of osteoporosis treatments.
Paget's Disease[edit]
Paget's disease of bone is characterized by excessive and disorganized bone remodeling. DPD levels can be significantly elevated in this condition, reflecting increased bone resorption.
Hyperparathyroidism[edit]
In hyperparathyroidism, increased secretion of parathyroid hormone leads to increased bone resorption. DPD levels can be used to monitor the severity of bone turnover in affected individuals.
Measurement[edit]
Deoxypyridinoline can be measured using immunoassay techniques. Urinary DPD levels are often expressed relative to creatinine to account for variations in urine concentration. This measurement is non-invasive and provides valuable information about bone metabolism.